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Aim: To analyze the effect of the two different versions of the manganese superoxide dismutase gene (SOD2)
on sepsis. The SOD2 gene presents the 47C>T single nucleotide polymorphism (SNP; ID: rs4880) which pro-
duces MnSODwith different activities. The−9Val MnSOD (47T allele) is less efﬁcient than the−9Ala version
(47C allele). During sepsis there are abundance of ROS, high SOD2 expression and excess of H2O2 synthesis.
High concentrations of H2O2 could affect the sepsis scenario and/or the sepsis outcome.
Methods: We determined the 47C>T single nucleotide polymorphism (SNP) frequencies in 529 critically ill
patients with or without sepsis, facing outcome. To collect information on population frequencies, we
obtained a pilot 47C>T genotypic and allelic frequencies in a random group of 139 healthy subjects.
Results:We compared the 47C allele carriers (47CC+47CT genotypes) with 47TT homozygotes and noticed a
signiﬁcant association between 47C allele carriers and septic shock in septic patients (P=0.025). With an ad-
justed binary multivariate logistic regression, incorporating 47C>T SNP and the main clinical predictors, we
showed high SOFA scores [Pb0.001, OR=9.107 (95% CI=5.319–15.592)] and 47C allele [P=0.011, OR=
2.125 (95% CI=1.190–3.794)] were signiﬁcantly associated with septic shock outcome. With this informa-
tion we presented a hypothesis suggesting that this negative outcome from sepsis is possibly explained by
effects on cellular stress caused by 47C allele.
Conclusion: In our population there was a signiﬁcant higher frequency of septic shock in septic patients with
the 47C allele of the SOD2 gene. This higher 47C allele frequency in septic patients with negative outcome
could be explained by effects of higher activity MnSOD on cellular stress during the sepsis.© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
The mitochondria milieu represents an abundant source of reac-
tive oxygen species (ROS), such as the superoxide anion (O2•−) that
is generated by incomplete reduction of molecular O2. In theition of Cytosine to Thymine at 47 nuc
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vier OA license.mitochondria, O2•− is converted into a less reactive species, such as
hydrogen peroxide (H2O2) by manganese-dependent superoxide
dismutase (MnSOD, EC 1.15.1.1) (Weisiger and Fridovich, 1973).
The gene that codiﬁes to manganese superoxide dismutase (SOD2
gene; locus 6q25) has a 47C>T single nucleotide polymorphismleotide of SOD2 gene; 47T, allelewith Thymine; 47TT, homozygote to Thymine allele of SOD2
from47C>T SNP of SOD2 gene; APACHE-II, Acute Physiology And Chronic Health Evaluation
genperoxide;HSL, São LucasHospital; ICU, Intensive CareUnit; IL, interleukin; LOS, length of
itochondrial DNA; MW,Mann–Whitney U-test; n, number; O2, molecular oxygen; O2•−, su-
iation of themean; SIRS, systemic inﬂammatory response syndrome; SNP, single nucleotide
n Failure Assessment; SPSS, statistical package; ST, Student's t-test; TNF-α, tumor necrosis
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cause this SNP modiﬁes the N-terminal mitochondrial targeting se-
quence from alanine (Ala; GCT codon) to valine (Val; GTT codon) at
position −9 of MnSOD signal peptide (Ala-9Val protein mutation)
(Rosenblum et al., 1996), the presence of alanine (−9Ala; 47C allele)
is predicted to lead to higher mitochondrial MnSOD activity than the
valine (−9Val; 47T allele) isoform (Hiroi et al., 1999). The −9Ala
MnSOD (codiﬁed by 47C allele) has an alpha-helical structure which
is a common conformation of mitochondrial leader signals, while
the −9Val MnSOD (codiﬁed by 47T allele) loses the alpha-helical
structure by a substitution at this residue (Shimoda-Matsubayashi
et al., 1996, 1997). Thereby, the −9Val MnSOD had demonstrated
to be less efﬁciently transported into mitochondria and to be signiﬁ-
cantly less efﬁcient than the −9Ala MnSOD (Hiroi et al., 1999;
Shimoda-Matsubayashi et al., 1996).
During sepsis, in response to lipopolysaccharide (LPS), increased
levels of tumor necrosis factor-α (TNF-α) and interleukin (IL)-1,
coupled to hypoxia leads to an excess of ROS and, due to the need to
convert O2•−, the SOD2 expression is induced (Wong and Goeddel,
1988) increasing both MnSOD and H2O2 (Guidot et al., 1993; Liu
et al., 2002; Taylor et al., 1995). Usually, the excess of H2O2 is rapidly
metabolized to O2 and H2O by glutathione peroxidase and catalase,
but very high H2O2 concentrations will induce mitochondrial DNA
strand breaks and mitochondrial dysfunction (Kaneko and Inoue,
1998; McDonald and Pan, 1993). The extension of oxidative cell dam-
age caused by the high concentrations of H2O2, however, will depend
onMnSOD activity and could affect the sepsis scenario and/or the sep-
sis outcome.
Concerning that the alterations on MnSOD activity causes an inad-
equate antioxidant defense and mitochondrial dysfunction (Williams
et al., 1998), it would be possible to propose theoretically that an ex-
cessive efﬁcient MnSOD activity (the 47C allele trait) would result in
higher mitochondrial dysfunction due to excess H2O2 production.
However, Elsakka et al. (2007) studying a sample of 40 septic patients
found a reduced frequency of 47T, but not 47C allele, in patients with
sepsis compared to healthy controls (n=100). Their pilot ﬁndings
concluded that the 47C>T SOD2 biallelic SNP had a functional effect
on sepsis: the authors argued that an inefﬁcient targeting of MnSOD
(the 47T allele trait) could result in the mitochondrial dysfunction ob-
served in sepsis by inadequate O2•− conversion.
Thus, we were interested in demonstrate whether 47C or 47T al-
lele carriers could be prone to higher oxidative stress and therefore
develop sepsis or worse outcome from sepsis. To analyze the effect
of the two different SOD2 versions on sepsis outcome, we determined
the 47C>T SNP frequencies in a sample of 529 well-characterized
critically ill patients.
2. Materials and methods
2.1. Design, subjects, and approval
This single center observational retrospective cohort study was
conducted with data from random patients admitted to the Intensive
Care Unit (ICU) of the São Lucas Hospital (HSL), Brazil, between
March 1st, 2002 and November 31st, 2006. The ICU-HSL is a general
non-pediatric Medical-Surgery Intensive Care Unit with 13 beds,
with 450 admissions/year. We worked on the archived DNA collec-
tion from septic and non-septic patients (controls). Patients were
followed until death or hospital discharge. Exclusion criteria were
HIV-infection, documented immunodeﬁciency, immunosuppressive
therapy, pregnant, or lactating. The control group was 139 random
healthy DNA donors from the Paternity Investigation Unit. All sub-
jects were from southern Brazil which is composed by a singular ge-
netic background: majority of subjects with European ethnicity
(Portuguese, Italian, Spanish, and German ancestry) and a small
amount of individuals with African traits contributing to their geneticpool (Parra et al., 2003; Salzano and Freire-Maia, 1970). The study
was approved by the Research Ethics Committee of the Pontiﬁcal
Catholic University of Rio Grande do Sul (Tel. +55 51 33203345; pro-
tocols #03-01732, and #07-03990), and the informed written con-
sent or assent to participate in was obtained from all subjects or
patients' surrogates.
2.2. Phenotyping
Patients admitted to the ICU, were diagnosed for sepsis, severe
sepsis and septic shock according to the American College of Chest
Physicians/Society of Critical Care Consensus Conference deﬁnition
(Bone et al., 1992). SIRS (systemic inﬂammatory response syndrome)
was deﬁned by the presence of at least two of the following symp-
toms: fever or hypothermia (core temperature>38 °C or b36 °C); tachy-
cardia (>90 beats/min); tachypnea or hyperventilation (breaths/
min>20 or PaCO2b32 mm Hg); leukocytosis (>12.000 mm3) or
leucopenia (b4.000 mm3). Sepsiswas deﬁned as SIRS secondary to infec-
tion, severe sepsis were sepsis complicated by organ dysfunction and,
septic shock if refractory arterial hypotension to ﬂuid replacement, need-
ing vasopressors.
For illness severity evaluation we used the APACHE-II (Acute Physi-
ology And Chronic Health Evaluation II) score (Knaus et al., 1985)
obtained on ICU admission day. Organ dysfunction evaluation was
according SOFA (Sequential Organ Failure Assessment) (Vincent et al.,
1998) score obtained on ICU admission day (SOFA-1) and daily during
the ﬁrst week from the ICU admission and in days 15 (SOFA-15) and
29 (SOFA-29) for patients that stayed in the ICU. Temporal variation
comprised length of stay (LOS) in ICU and hospital stay. Mortality was
measured in days until death in total hospital stay: clinical endpoints
of the study were discharge from the hospital (considered survivors),
or death (considered non-survivors). For those patients with multiple
ICU admission during the study period, only data from theﬁrst entrance
was considered. All clinical data were collected and veriﬁed by ICU phy-
sicians with control ensure.
2.3. Genotyping
Genomic DNA was extracted from leucocytes by a standard meth-
od (Lahiri and Nurnberger, 1991). We used previously described
genotyping protocols for the determination of 47C>T SOD2 SNP
(rs4880) (Taufer et al., 2005): Polymerase Chain Reaction (PCR) was
performed at a total volume of 25 μL with about 10–100 ng of
genomic DNA, 1.6 U Taq DNA Polymerase in Taq Buffer (Life
Technologies — Brazil Ltda. INVITROGEN Inv. São Paulo, SP, Brazil),
ﬁnal concentration of each dNTP 0.2 mM, and 2 mM MgCl2, 10%
DMSO. The exon 2 segment of the SOD2 gene was ampliﬁed using
primers sense 5′-GCC CAG CCT GCG TAG ACG GTC CC-3′, and
anti-sense 5′-TGC CTG GAG CCC AGA TAC CCC AAG-3′ (Life
Technologies — Brazil Ltda. INVITROGEN Inv. São Paulo, SP, Brazil)
where the underlined nucleotide represents the deliberate primer
mismatches designed to introduce artiﬁcial restriction site (Taufer
et al., 2005). The PCR was performed on an PTC-100 thermocycler
(MJ Research, Inc. Watertown, MA, USA), as follows: an initial dena-
turation at 95 °C for 6 min, followed by 35 cycles at 95 °C for 1 min,
at 60 °C for 1 min, and at 72 °C for 1 min and 30 s. The ﬁnal extension
step was prolonged to 7 min. The 110 bp PCR ampliﬁed product
(25 μL) was cleaved in appropriated buffer with 10U of the HaeIII
(GibcoBRL®-Life Technologies™, Rockville, MD, USA) at a total vol-
ume of 15 μL at 37 °C for 8 h. At least 15% of the samples were
subjected to a second, independent PCR restriction fragment
length-polymorphism analysis in order to conﬁrm their genotypes.
Based in HapMap, there is an expected high enough prevalence
of the 47C>T SNP in our population: Global 47C=0.48, 47T=0.52;
European 47C=0.44, 47T=0.56; Sub-Saharan African 47C=0.36,
47T=0.64 (http://www.hapmap.org/), even so in order to have
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47C>T genotypic and allelic frequencies in healthy controls. Those
data are: 47CC=0.29, 47CT=0.41, 47TT=0.30 and 47C=0.50,
47T=0.50; Chi-squared test Hardy–Weinberg equilibrium P=0.034.
We did not use healthy subjects as control group because we assumed
that the environmental exposure has a crucial inﬂuence, therefore we
performed comparison among ICU patients. We used a quality control
system to ensure genotyping accuracy: sequencing veriﬁcation of the
DNA ampliﬁed fragment, black controls, and repetitions. In order to
conﬁrm that the 110 bp PCR ampliﬁed product really represented the
targeted product, we performed a sequence analysis in MegaBase
1000 capillary DNA sequencer (Amersham Biosciences UK Ltd, Chalfont
St Giles, Bucks, UK) using the same designed primers. The sequence
obtained was submitted to a nucleotide–nucleotide BLAST online align-
ment (blast, at http://www.ncbi.nlm.nih.gov/BLAST/) with the data-
bases, and we found consensus with the Homo sapiens manganese
superoxide dismutase gene, exon 2 DNA sequence (GenBank accession
# D83493-region 351, GI:1841351) and the sequence exported from
chromatogram ﬁle. The alignment view was performed in ClustalX
program (version 1.8, as described at ftp://ftp-igbmc.u-strasbg.fr/
pub/ClustalX/) in multiple alignment modes, with sequences loaded
in FASTA format. The lab technicians were blinded to phenotype, and
clinical investigators blinded to genotype.
2.4. Statistical analysis
Statistical analyses were conducted using the SPSS 11.5 statis-
tical package (SPSS, Chicago, USA). Continuous variable results are
expressed as mean±standard deviation (SD) and the categorical vari-
ables as frequencies and percents. Non-normally distributed scalar vari-
ables were analyzed as non-parametric using the Kruskal–Wallis and
Mann–Whitney tests. For categorical data, we used the Pearson Chi-
squared test. To test Hardy–Weinberg equilibrium, the Chi-squared
test was used. To evaluate the inﬂuence of individual genotype on
the patient outcome, excluding other risk factors that could inﬂuence
the outcome, we used multiple forward stepwise multivariate logisticTable 1
Demographic, clinical and genetic proﬁle of 529 critically ill patients with and without sep
Variables All
Patients [n (%)] 529 (100)
Male [n (%)] 285 (53.6)
Age [years; mean (SD)] 54.8 (20.0)
Admission cause — Medical [n (%)] 443 (83.7)
APACHE II [mean (SD)] 19.6 (7.9)
SOFA-1 [median (min/max)] 6 (0/18)
SOFA-2 [median (min/max)] 6 (0/18)
SOFA-3 [median (min/max)] 6 (0/18)
SOFA-4 [median (min/max)] 6 (0/19)
SOFA-5 [median (min/max)] 5 (0/20)
SOFA-6 [median (min/max)] 5 (0/21)
SOFA-7 [median (min/max)] 5 (0/24)
SOFA-15 [median (min/max)] 5 (0/19)
SOFA-29 [median (min/max)] 4 (0/16)
ICU LOS [days; median (min/max)] 15 (0/125)
Hospital LOS [days; median (min/max)] 36 (1/242)
47CC [n (%)] 128 (24.2)
47CT [n (%)] 266 (50.3)
47TT [n (%)] 135 (25.5)
47CC+47CT [n (%)] 394 (74.5)
47TT+47CT [n (%)] 401 (75.8)
47C allele [n (%)] 522 (49.0)
47T allele [n (%)] 536 (51.0)
Mortality [n (%)] 243 (46.2)
47C carriers: 47CC homozygotes and 47CT heterozygotes to 47C>T SOD2 SNP; 47TT patien
SOFA: Sequential Organ Failure Assessment; ICU: Intensive Care Unit; Hospital: ICU plus hos
t-test; MW: Mann–Whitney U-test; X2: Pearson Chi-squared test; P value describes a compa
47TT homozygotes; (b) 47TT+47CT genotypic group versus 47CC homozygotes.regression analysis (Wald method), incorporating patients with and
without 47C allele and the clinical predictors. The subjects were classi-
ﬁed according to their cutoff value for positive classiﬁcation in the ROC
curve analysis. The primary outcome measure was sepsis. For septic
patients the primary outcome measure was septic shock. For inclusion
of variables in themultivariatemodel of logistic regression,we adopted,
a correlation between septic shock or mortality and each independent
variable at a signiﬁcance level (P value) lower than 0.25 (Moraes and
Souza, 2005). Hazard function analysis by the Kaplan–Meier (Log-rank
statistic) procedure was also applied. All reported P values are two-
tailed and considered statistically signiﬁcant when 0.05 or less.3. Results
We obtained data from 529 patients admitted to the ICU to a max-
imum of 224 days. Part of these patients was described by Paskulin et
al., 2011. Table 1 describes patient proﬁle (n=529) grouped
according to sepsis phenotype: patients with (n=356; 67.3%) and
without (n=173; 32.7%) sepsis. Among septic patients, 99.7% (355/
356) acquired sepsis before ICU admission. The high incidence of sep-
sis and septic shock was attributed to the nature ICU. Demographic,
clinical, and genetic characteristics were stated: the two groups had
signiﬁcant differences in several parameters. The general genotypic
and allelic frequencies in ICU sample (n=529) did not differ from
the values expected by the Hardy–Weinberg model (P=0.893). The
frequencies from sub-samples obtained from patients with or with-
out sepsis show that there were also no deviation from equilibrium
[septic: 47CC=0.25 (89/356), 47CT=0.49 (176/356), 47TT=0.26
(91/356) and 47C=0.50 (354/712), 47T=0.50 (358/712); P=
0.833; non-septic: 47CC=0.23 (39/173), 47CT=0.52 (90/173),
47TT=0.25 (44/173) and 47C=0.49 (168/346), 47T=0.51 (178/
346); P=0.587]. Comparing patients with and without sepsis in the
whole sample (n=529) we did not ﬁnd signiﬁcant association be-
tween sepsis and 47C>T SOD2 genotypes (P=0.800) or alleles
(P=0.722).sis.
With sepsis Without sepsis P
356 (67.3) 173 (32.7)
191 (53.7) 92 (53.2) 0.919X
2
56.0 (19.5) 52.3 (20.8) 0.047ST
309 (86.8) 134 (77.5) 0.006X
2
21.0 (7.0) 16.5 (8.2) 0.291ST
8 (0/18) 4 (0/17) 0.000MW
7 (0/18) 4 (0/14) 0.000MW
7 (0/18) 4 (0/13) 0.000MW
6 (0/19) 4 (0/14) 0.000MW
6 (0/20) 4 (0/14) 0.000MW
6 (0/21) 3 (0/14) 0.000MW
6 (0/24) 4 (0/12) 0.000MW
6 (0/19) 3 (0/10) 0.000MW
6 (0/16) 3 (0/08) 0.004MW
15 (0/118) 11 (1/125) 0.000MW
36 (1/165) 35.5 (1/242) 0.502MW
89 (25.0) 39 (22.5) 0.800X
2
176 (49.4) 90 (52.1)
91 (25.6) 44 (25.4)
265 (74.4) 129 (74.6) 0.975X
2 (a)
267 (75.0) 134 (77.5) 0.536X
2 (b)
354 (50.0) 168 (48.0) 0.722X
2
358 (50.0) 178 (52.0)
198 (55.9) 45 (26.2) 0.000X
2
ts: 47TT homozygotes; APACHE-II: Acute Physiology and Chronic Health Evaluation II;
pital; LOS: length of stay; n: number; SD: standard deviation of the mean; ST: Student's
rison between septic and non-septic patients; (a) 47CC+47CT genotypic group versus
Table 2
Adverse outcomes from sepsis in the septic patient's subgroup by 47C>T SOD2 SNP:
(A) septic shock; (B) mortality.
A — Septic shock from sepsis With
septic
shock
Without
septic
shock
P
Patients [n (%)] 252 (70.8) 104 (29.2)
Male [n (%)] 135 (53.6) 56 (53.8) 0.962X
2
Age [years; mean (SD)] 56.1 (18.7) 55.7 (21.5) 0.865ST
Nosocomial infection [n (%)] 127 (50.4) 49 (47.1) 0.573X
2
Admission cause — Medical [n (%)] 221 (87.7) 88 (84.6) 0.434X
2
APACHE II [mean (SD)] 21.6 (7.0) 19.2 (7.7) 0.004ST
SOFA-1 [median (min/max)] 8 (1/18) 4 (0/13) 0.000MW
SOFA-2 [median (min/max)] 8 (0/18) 4.5(0/15) 0.000MW
SOFA-3 [median (min/max)] 8 (0/18) 5 (0/15) 0.000MW
SOFA-4 [median (min/max)] 7 (0/19) 5 (0/14) 0.000MW
SOFA-5 [median (min/max)] 7 (0/20) 4 (0/18) 0.000MW
SOFA-6 [median (min/max)] 7 (0/21) 4 (0/17) 0.000MW
SOFA-7 [median (min/max)] 7 (0/24) 4 (0/18) 0.000MW
SOFA-15 [median (min/max)] 6 (0/19) 4 (0/16) 0.019MW
SOFA-29 [median (min/max)] 6 (0/16) 4 (0/09) 0.096MW
ICU LOS [days; median (min/max)] 15 (0/118) 13 (2/107) 0.014MW
Hospital LOS [days; median (min/max)] 36 (3/165) 36 (1/156) 0.962MW
47CC [n (%)] 65 (25.8) 24 (23.1)
47CT [n (%)] 131 (52.0) 45 (43.2) 0.078X
2
47TT [n (%)] 56 (22.2) 35 (33.7)
47CC+47CT [n (%)] 196 (77.8) 69 (66.3) 0.025X
2 (a)
47TT+47CT [n (%)] 187 (74.2) 80 (76.9) 0.536X
2 (b)
47C allele [n (%)] 261 (51.8) 93 (44.7) 0.086X
2
47T allele [n (%)] 243 (48.2) 115 (55.3)
Mortality [n (%)] 161 (64.1) 37 (35.9) 0.000X
2
B — Mortality from sepsis Non Survivor Survivor P
Patients [n (%)] 198 (55.9) 156 (44.1)
Male [n (%)] 104 (52.5) 87 (55.8) 0.543X
2
Age [years; mean (SD)] 61.5 (16.9) 49.4 (20.4) 0.000ST
Nosocomial infection [n (%)] 111 (56.1) 63 (40.4) 0.003X
2
Admission cause — Medical [n (%)] 175 (88.4) 133 (85.3) 0.385X
2
APACHE II [mean (SD)] 23.0 (6.8) 18.3 (7.1) 0.000ST
SOFA-1 [median (min/max)] 8 (1/16) 7 (0/18) 0.000MW
SOFA-2 [median (min/max)] 8 (0/18) 6 (0/16) 0.000MW
SOFA-3 [median (min/max)] 8 (0/18) 6 (0/18) 0.000MW
SOFA-4 [median (min/max)] 7 (0/19) 5 (0/17) 0.000MW
SOFA-5 [median (min/max)] 7.5(0/20) 5 (0/18) 0.000MW
SOFA-6 [median (min/max)] 7 (0/21) 5 (0/16) 0.000MW
SOFA-7 [median (min/max)] 7 (0/24) 4 (0/15) 0.000MW
SOFA-15 [median (min/max)] 7 (0/19) 3 (0/16) 0.000MW
SOFA-29 [median (min/max)] 7 (2/16) 3 (0/11) 0.007MW
ICU LOS [days; median (min/max)] 16 (0/107) 14 (2/82) 0.122MW
Hospital LOS [days; median (min/max)] 32 (3/156) 40 (1/165) 0.003MW
Septic shock [n (%)] 161 (81.3) 90 (57.7) 0.000X
2
47CC [n (%)] 45 (22.7) 43 (27.6) 0.022X
2
47CT [n (%)] 111 (56.1) 65 (41.7)
47TT [n (%)] 42 (21.2) 48 (30.8)
47CC+47CT [n (%)] 156 (78.8) 108 (69.2) 0.040X
2 (a)
47TT+47CT [n (%)] 153 (77.3) 113 (72.4) 0.296X
2 (b)
With 47C allele [n (%)] 201 (50.8) 151 (48.4) 0.533X
2
With 47T allele [n (%)] 195 (49.2) 161 (51.6)
47C carriers: 47CC homozygotes and 47CT heterozygotes to 47C>T SOD2 SNP; 47TT
patients: 47TT homozygotes; APACHE-II: Acute Physiology and Chronic Health Evalua-
tion II; SOFA: Sequential Organ Failure Assessment; ICU: Intensive Care Unit; Hospital:
ICU plus hospital; LOS: length of stay; n: number; SD: standard deviation of the mean;
ST: Student's t-test; MW: Mann–Whitney U-test; X2: Pearson Chi-squared test; P value
describes a comparison between septic and non-septic patients; (a) 47CC+47CT geno-
typic group versus 47TT homozygotes; (b) 47TT+47CT genotypic group versus 47CC
homozygotes.
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(septic shock and mortality) from sepsis in the septic patient's sub-
group (Table 2). Demographic, clinical, and genetic characteristics
showed signiﬁcant differences in some parameters. When compared
the three genotype groups (47CC, 47CT, 47TT) separately, we found
a trend to septic shock (P=0.078) and an unadjusted statistic associ-
ation with mortality (P=0.022). When we compared the 47C allele
carriers group (47CC+47CT genotypes) with 47TT homozygotes, asigniﬁcant positive, unadjusted association with septic shock (74.0 vs
61.5; P=0.025; OR=1.78, 95% CI=1.04–3.03) and mortality was ob-
served (59.1 vs 46.7; P=0.040; OR=0.61, 95% CI=0.36–1.01). In the
allele analysis septic shock (P=0.086), but not mortality (P=0.533),
showed a trend towards association with 47C allele.
In order to test whether it would be acceptable or it would just be
likely causality of this genetic study, we performed binary multivari-
ate logistic regression to an adjusted analysis, incorporating both 47C
carriers and 47TT homozygotes and the main clinical predictors such
as age and organ dysfunction (SOFA) to exclude other risk factors that
could inﬂuence the outcome (Table 3). Taking all patients together
(n=529), step 2 (ﬁnal) of the forward stepwise (Wald) method
showed that only SOFA [Pb0.001, OR=10.677 (95% CI=6.942–
16.422)], and 47C allele [P=0.016, OR=1.748 (95% CI=1.108–
2.758)] were signiﬁcantly associated with septic shock outcome.
Among septic patients (n=356), also step 2 of the forward stepwise
method showed that only SOFA-day1 [Pb0.001, OR=9.107 (95%
CI=5.319–15.592)], and 47C allele [P=0.011, OR=2.125 (95%
CI=1.190–3.794)] were signiﬁcantly associated with septic shock
outcome. In the binary multivariate logistic regression analysis for
mortality, among all patients or septic patients we did not ﬁnd signif-
icant association with the 47C>T genotype groups (P=0.413 and
P=0.132, respectively).
To reanalyze the mortality, we also performed a hazard function
analysis by Kaplan–Meier analysis using the 47C>T genotype groups
as a discriminating factor. Among all patients, we observed that those
carrying the 47C allele did not have worse outcome (Log-rank statis-
tic, P=0.9147) when compared to the 47TT homozygotes. The same
analysis was conducted on patients with only sepsis (n=356) and
septic shock (n=252), and mortality distribution patterns were dif-
ferent although not statistically signiﬁcant (Log-rank statistic, P=
0.1944 and P=0.3250, respectively).
4. Discussion
Our results in a ICU population indicated the 47C SOD2 allele car-
riers (47CT and 47CC genotypes), in comparison with 47TT homozy-
gote group, did not showed association with sepsis. Among septic
patients, a signiﬁcant association between the 47C SOD2 allele with
of septic shock was identiﬁed. This last association was supported
by a modest predisposing effect of the allele on mortality in septic pa-
tients. Based on the functional evidence that 47C allele (−9Ala
MnSOD) leads to higher mitochondrial MnSOD activity (Hiroi et al.,
1999), our analysis are in accordance with a substantial inﬂuence of
the 47C allele on the clinical outcome. However, our hypothesis re-
quires validation in additional large cohorts.
Hiroi et al. (1999) examined themitochondrial processing efﬁcien-
cy of both−9Val and−9Ala MnSOD leader signals and demonstrated
that the −9Val version was signiﬁcantly less efﬁciently processed
than the−9Ala MnSOD. Before these study, some populational stud-
ies have suggested an important role of the 47C>T SOD2 SNP in
human diseases. Since the mitochondria are protected from O2•− by
MnSOD enzyme, cells could become susceptible to O2•−-related dam-
ages when the activity of MnSOD in the mitochondria is reduced. For
instance, individual variability of these enzymes (polymorphisms)
leading to lower antioxidant activity in brain cells could be hypothe-
sized to play a role in schizophrenia, as proposed by Akyol et al.
(2005). However, still remains some inconsistency. Disease associa-
tions in one population cannot be conﬁrmed in others, for example, dis-
crepancies to cancer predisposition in three different North American
populations (Egan et al., 2003; Millikan et al., 2004; Wang et al.,
2001). In line, the phenotypical inﬂuence of 47C>T SNP on sepsis or
mortality is also unknown. In our study we did not ﬁnd any association
between sepsis and 47C>T SOD2 genotypes. Despite our results, a pos-
itive association between 47C allele carriers and sepsis was found
in a pilot study that compared 40 septic patients (with four 47TT
Table 3
Septic shock outcome risk analysis by binary logistic regression of the forward stepwise (Wald) method: (A) all critically ill patients (n=529); (B) septic patients subgroup
(n=356).
(A)
Step
Variable in the equation P Wald X2 β S.E. (β) Odds ratio⁎
(95% CI)
Percent of correct prediction
1 Category SOFA b0.001 114.86 2.32 0.216 10.171(6.655–15.545) 74.2
2 Category SOFA b0.001 116.23 2.37 0.220 10.677(6.942–16.422) 74.2
47C allele 0.016 5.76 0.56 0.233 1.748 (1.108–2.758)
Step Variable not in the equation P Score
1 Category age 0.589 0.292
47C allele 0.016 5.809
2 Category age 0.752 0.100
(B)
Step
Variable in the equation P Wald X2 β S.E. (β) Odds ratio⁎
(95% CI)
Percent of correct prediction
1 Category SOFA b0.001 64.16 2.14 0.267 8.516 (5.042–14.383) 77.7
2 Category SOFA b0.001 64.82 2.21 0.274 9.107 (5.319–15.592) 77.7
47C allele 0.011 6.50 0.75 0.296 2.125 (1.190–3.794)
Step Variable not in the equation P Score
1 Category age 0.865 0.029
2 Category age 0.627 0.236
47C allele 0.010 6.643
47C carriers: 47CC homozygotes and 47CT heterozygotes to 47C>T SOD2 SNP; β: coefﬁcient of regression; S.E.: standard error; 95% CI: 95% conﬁdence interval.
⁎ Odds ratio: classiﬁcation of a successful septic shock outcome.
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disagreement between Elsakka's and our results could be related
to: 1— different sample sizes (septic=356/non-septic=173 vs sep-
tic=40/non-septic=100); 2 — diverse control groups (ICU patients
without sepsis vs healthy non-ICU volunteers); and 3— diverse genetic
background of the casuistic (United Kingdom vs southern Brazil). Re-
garding the ethnic origin, subjects from the southern Brazilian pop-
ulation comprise a singular genetic background with the majority of
subjectswith European origin (Portuguese, Italian, Spanish, andGerman
ancestry) and a smaller amount of individuals with African traits con-
tributing to their genetic pool (Parra et al., 2003; Salzano and
Freire-Maia, 1970). In our previous 47C>T analysis with healthy sub-
jects we obtained balanced genotypic frequencies and the allelic fre-
quencies (47C=0.50, 47T=0.50) were comparable to other two
studies with similar population: 47C=0.42; 47T=0.58 (Taufer et al.,
2005) and 47C=0.49; 47T=0.51 (Gottlieb et al., 2005). Each one
were closed to global prevalence of this SNP (source from HapMap:
47C=0.48; 47T=0.52). We noticed that our non-septic ICU patients
group had a similar allelic frequencies (47C=0.48; 47T=0.52) as the
healthy subjects.
It was also detected in peripheral blood mononuclear cells from
ten healthy subjects that, despite predictions from structural enzyme
studies, there was no difference between genotypes in MnSOD activ-
ity after LPS exposition (Elsakka et al., 2007). Based on our results we
can infer that MnSOD activity might have more inﬂuence on worsen-
ing an established sepsis than in predisposing it, e.g., the MnSOD var-
iants could affect the susceptibility to septic shockmore than to sepsis
from critical illness. The literature shows that during sepsis the O2•−
synthesis is increased; uncoupling of electron transport may occur
and O2•− production most likely increases even when O2•− tension
is normal or low (Guidot et al., 1993). Likewise, the MnSOD expres-
sion is prone to convert the O2•− in H2O2. For instance, Suliman et
al. demonstrated that LPS of Gram-negative bacteria depleted gluta-
thione (GSH) and increased mitochondrial lipid peroxidation in con-
junction with increased MnSOD gene expression (Suliman et al.,
2003). These factors stimulate cytokine and ROS production causing
damage in mtDNA by oxidizing and decreasing copy number.
Even though the present study is associative and does not allow
drawing deﬁnitive conclusion about cellular mechanisms of oxida-
tion, we could speculate that a more efﬁcient MnSOD activity (the47C allele trait) results in mitochondrial dysfunction due to higher
H2O2 production, especially during sepsis, when there is an excess
in H2O2 combined with higher SOD2 expression and GSH depletion.
This is a preliminary hypothesis, since the complete cellular mecha-
nism cannot be supported by our current data. It is also important
to emphasize that no independent association was detected between
47CC homozygotes and adverse outcome from sepsis, possibly caused
by the high rates of organ dysfunction in critically ill patients.
We did not measure MnSOD levels or activity to correlate with
SOD2 alleles because that was already done by other studies
(Elsakka et al., 2007; Sutton et al., 2005). We recognize that neither
haplotyped-based nor cluster-based SOD2 gene approach can be a
limitation and that multiple-marker studies are more precise than
the analysis of a single target. Despite this limitation, we were able
to detect a signiﬁcant effect of 47C SOD allele on septic shock, show-
ing that this unique SNP study may be biological reasonable, i.e., there
is a plausible effect of gene product on outcome from an inﬂammato-
ry condition. To answer whether it would be acceptable or just be
likely a causality of genetic association study, we performed a binary
multivariate logistic regression to an adjusted analysis incorporating
the main clinical predictors to exclude other risk factors that could in-
ﬂuence the outcome. This last analysis conﬁrmed that a factual asso-
ciation likely exists between genotype and phenotype.
Finally, we propose that further SNP-array investigations should
include the 47C>T SOD2 SNP alone or in combination with other
functionally relevant SNP. Broader advanced studies including addi-
tional candidate SOD2 SNPs and genes such as SOD3, SOD1, eNOS (en-
dothelial nitric oxide synthase), GPx-1 (glutationa peroxidase 1),
GPx-3, GPx-4, or CAT (catalase) could also help to reﬁne the under-
standing about septic shock predisposition.5. Conclusions
In conclusion, we demonstrated that the 47C>T (Ala-9Val) SOD2
SNP did not inﬂuence sepsis susceptibility, but it was associated
with adverse outcome from sepsis: there was a signiﬁcant higher fre-
quency of septic shock in 47C allele carriers group than in 47TT ho-
mozygotes. Our results and our hypothesis suggest that the higher
47C allele carrier frequency in septic patients with negative outcome
111F.J.O. Paludo et al. / Gene 517 (2013) 106–111is possibly explained by effects of higher activity MnSOD on cellular
stress during the sepsis.
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